Cargando…
Toxic epidermal necrolysis (TEN) associated with the use of nivolumab (PD-1 inhibitor) for lymphoma
Autores principales: | Griffin, Liezel L., Cove-Smith, Laura, Alachkar, Hana, Radford, John A., Brooke, Rebecca, Linton, Kim M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909477/ https://www.ncbi.nlm.nih.gov/pubmed/29687056 http://dx.doi.org/10.1016/j.jdcr.2017.09.028 |
Ejemplares similares
-
Toxic epidermal necrolysis associated with nivolumab treatment for head and neck cancer
por: Koshizuka, Keiichi, et al.
Publicado: (2020) -
Nivolumab-Induced Toxic Epidermal Necrolysis: Rare but Fatal Complication of Immune Checkpoint Inhibitor Therapy
por: Kim, Michael C, et al.
Publicado: (2021) -
Allopurinol-Induced Uncommon Dermatological Emergency of Toxic Epidermal Necrolysis (TEN)
por: Pabani, Umesh Kumar, et al.
Publicado: (2023) -
Toxic Epidermal Necrolysis
por: Khalifian, Saami, et al.
Publicado: (2014) -
Toxic epidermal necrolysis
por: Hoetzenecker, Wolfram, et al.
Publicado: (2016)